Allan RyanFeb 6, 20232 minSecukinumab shows positive effects in HS at 52 weeksPatients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...
John EvansFeb 14, 20222 minPsoriatic inflammation improves with bile acidsSome bile acids may help to improve or prevent the skin inflammation associated with psoriasis, according to the results of a study...
John EvansAug 9, 20211 minTwo-year data indicates bimekizumab maintains high levels of psoriatic skin clearanceStudy results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...